H. pylori and stomach cancer: what the new research means

Published October 6, 2026. · 4 min read

H. pylori can contribute to stomach cancer, but an H. pylori infection is not a cancer diagnosis. Most people with the infection do not develop stomach cancer. The useful next step is to understand whether testing and medical follow-up fit your circumstances. Cleveland Clinic

CNN's October 5 report draws attention to a worldwide estimate of cancers attributable to infections. The findings do not mean that everyone with a common infection is likely to develop cancer—or that buying a particular stool test prevents it.

What did the new study find?

Researchers at the International Agency for Research on Cancer estimated that infections accounted for approximately 2.3 million new cancer cases worldwide in 2024, or 12% of all new cancers. Within that total, an estimated 760,000 cases were attributable to H. pylori, mainly stomach cancers. The 2.3 million figure covers multiple infections, not H. pylori alone. IARC press release

The study, Global burden of cancer attributable to infections in 2024: a worldwide incidence analysis, was published online in The Lancet Oncology on September 28, 2026. Its publication date and its study year are different.

The researchers used GLOBOCAN estimates and calculated the share of cancers attributable to 12 infectious agents. They grouped estimates by characteristics including age, sex and country. This was a population analysis, not a trial comparing tests or following people after they bought a home kit. Study abstract

Does “12%” describe my cancer risk?

No. It describes a fraction of cancer cases across a population. It does not mean that 12% of people with an infection will develop cancer.

These are different questions:

The research question The personal question
How many cancers in a population can be attributed to infections? What does my medical history mean for my future health?
Which infections contribute most to that burden? Should I be tested, treated or assessed further?
Where might prevention programs help? What care is appropriate for me now?

An individual assessment needs information the headline cannot provide, such as family history and any previous findings in the stomach lining. The National Cancer Institute identifies chronic H. pylori infection as one of several stomach cancer risk factors. NCI risk factors

Why is H. pylori connected with stomach cancer?

H. pylori is a bacterium that can remain in the stomach and cause prolonged inflammation. In some people, changes in the stomach lining can progress over time. Infection is also linked to gastric MALT lymphoma, an uncommon cancer involving immune cells in the stomach. Treating the infection can reduce gastric cancer risk, but it does not guarantee that cancer will never develop. NCI explanation

“Carcinogenic” describes the ability to cause cancer. It is not a prediction that a particular person will develop it. Equally, the fact that most infected people do not develop cancer is not a reason to ignore a confirmed infection.

Does the study show a sudden increase this week?

No. A new publication can draw attention to an existing health issue. It does not establish a sudden rise in infections or cancers around the date of a news story.

The updated research also includes infection–cancer relationships that were not in earlier global estimates. Differences between editions therefore need careful interpretation; they cannot automatically be treated as a change in disease rates. IARC research Q&A

Should the news prompt me to get tested?

It can be a reason to discuss your history with a clinician. It is not, by itself, a reason for everyone to buy a test. Tell your clinician about persistent upper-abdominal symptoms, previous ulcers, a close family history of stomach cancer, prior H. pylori treatment and any known stomach-lining changes. US guidance uses clinical indications to decide who should be tested. ACG guidance

A test for H. pylori looks for evidence of infection. It does not diagnose or exclude stomach cancer. A GI-MAP virulence-gene finding also cannot tell you whether you will develop cancer. The next step depends on the clinical question, not how alarming a result looks on a report.

If your clinician recommends testing, our comparison of H. pylori test methods explains the options and their limits.

Vomiting blood, black tarry stools, fainting or severe persistent abdominal pain warrant immediate medical attention. Do not wait for a mail-in kit to investigate those symptoms. MedlinePlus

A practical next step: use our H. pylori guide to prepare for a conversation about symptoms, testing and follow-up. If you already have a report, our H. pylori biomarker explanation describes the separate types of information it contains.

Sources: IARC press release and Q&A (September 28, 2026); Rumgay et al., DOI 10.1016/S1470-2045(26)00307-4, publisher-hosted abstract; NCI; ACG 2024; Cleveland Clinic; MedlinePlus. Links appear beside the relevant claims.

For a correction or source question, contact GI MAP Test.

Order Your GI-MAP™ Test →